Inosine induces stemness features in CAR-T cells and enhances potency
Stanford University · Gladstone Institutes · +2 more institutions
Abstract
CAR-T cells express CD39 and CD73, which mediate proximal steps in Ado generation. Here, we sought to enhance CAR-T cell potency by knocking out CD39, CD73, or adenosine receptor 2a (A2aR) but observed only modest effects. In contrast, overexpression of Ado deaminase (ADA-OE), which metabolizes Ado to inosine (INO), induced stemness and enhanced CAR-T functionality. Similarly, CAR-T cell exposure to INO augmented function and induced features of stemness. INO induced profound metabolic reprogramming, diminishing glycolysis, increasing mitochondrial and glycolytic capacity, glutaminolysis and polyamine synthesis, and reprogrammed the epigenome toward greater stemness. Clinical scale manufacturing using INO…
Citation impact
- FWCI
- 34.37
- Percentile
- 100%
- References
- 76
Authors
27Topics & keywords
- Glutaminolysis
- Cell biology
- Autophagy
- Reprogramming
- Potency
- Tumor microenvironment
- Inosine
- Cancer research
Funding
- CRCancer Research Institute
- MMerck
- SBSt. Baldrick's Foundation
- VAVirginia and D.K. Ludwig Fund for Cancer Research
- PIParker Institute for Cancer Immunotherapy
- ANAlliance Nationale pour les Sciences de la Vie et de la Santé
- FPFondation pour la Recherche Nuovo-Soldati
- NCNational Cancer InstituteAwards: 5P30CA124435, U54CA232568–01
- SMStanford Maternal and Child Health Research InstituteAward: R01 CA251858-01A1S1
- ATAllogene Therapeutics